BIOMARIN PHARMACEUTICAL INC Quarterly Entity Common Stock, Shares Outstanding from Q2 2010 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Biomarin Pharmaceutical Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2010 to Q3 2024.
  • Biomarin Pharmaceutical Inc Entity Common Stock, Shares Outstanding for the quarter ending October 28, 2024 was 191M shares, a 1.18% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 191M +2.21M +1.18% Oct 28, 2024 10-Q 2024-10-31
Q2 2024 190M +2.21M +1.17% Jul 31, 2024 10-Q 2024-08-05
Q1 2024 190M +2.18M +1.16% Apr 22, 2024 10-Q 2024-04-26
Q3 2023 188M +2.52M +1.36% Oct 30, 2023 10-Q 2023-11-02
Q2 2023 188M +2.7M +1.46% Jul 28, 2023 10-Q 2023-08-02
Q1 2023 188M +2.71M +1.46% Apr 25, 2023 10-Q 2023-04-28
Q3 2022 186M +2.26M +1.23% Oct 25, 2022 10-Q 2022-10-28
Q2 2022 185M +2.12M +1.16% Jul 28, 2022 10-Q 2022-08-04
Q1 2022 185M +2.25M +1.23% Apr 25, 2022 10-Q 2022-04-29
Q3 2021 184M +2.06M +1.14% Oct 26, 2021 10-Q 2021-10-29
Q2 2021 183M +2M +1.1% Jul 27, 2021 10-Q 2021-07-30
Q1 2021 183M +1.91M +1.05% Apr 21, 2021 10-Q 2021-04-30
Q4 2020 182M +1.9M +1.06% Feb 12, 2021 10-K 2021-02-26
Q3 2020 182M +1.9M +1.06% Oct 23, 2020 10-Q 2020-11-06
Q2 2020 181M +1.89M +1.05% Jul 30, 2020 10-Q 2020-08-05
Q1 2020 181M +1.77M +0.99% Apr 20, 2020 10-Q 2020-05-01
Q4 2019 180M +1.55M +0.87% Feb 12, 2020 10-K 2020-02-27
Q3 2019 180M +1.56M +0.88% Oct 18, 2019 10-Q/A 2019-11-04
Q2 2019 179M +1.87M +1.05% Jul 22, 2019 10-Q 2019-08-02
Q1 2019 179M +2.36M +1.33% Apr 15, 2019 10-Q 2019-04-29
Q4 2018 178M +2.3M +1.31% Feb 12, 2019 10-K 2019-02-28
Q3 2018 178M +2.44M +1.39% Oct 19, 2018 10-Q 2018-10-26
Q2 2018 178M +2.32M +1.33% Jul 23, 2018 10-Q 2018-08-03
Q1 2018 177M +2.22M +1.27% Apr 13, 2018 10-Q 2018-04-27
Q4 2017 176M +3.21M +1.85% Feb 13, 2018 10-K 2018-02-26
Q3 2017 176M +3.63M +2.11% Oct 25, 2017 10-Q 2017-10-31
Q2 2017 175M +11.8M +7.22% Jul 20, 2017 10-Q 2017-08-02
Q1 2017 174M +12.2M +7.5% Apr 20, 2017 10-Q 2017-05-04
Q4 2016 173M +11.3M +6.98% Feb 13, 2017 10-K 2017-02-27
Q3 2016 172M +10.7M +6.66% Oct 28, 2016 10-Q 2016-11-03
Q2 2016 163M +2.37M +1.47% Jul 29, 2016 10-Q 2016-08-08
Q1 2016 162M +1.99M +1.24% Apr 22, 2016 10-Q 2016-05-02
Q4 2015 162M +2.45M +1.54% Feb 12, 2016 10-K 2016-02-29
Q3 2015 161M +13.8M +9.35% Oct 23, 2015 10-Q 2015-11-02
Q2 2015 161M +14M +9.5% Jul 27, 2015 10-Q 2015-08-05
Q1 2015 160M +14.4M +9.88% Apr 24, 2015 10-Q 2015-05-05
Q4 2014 159M +15.5M +10.8% Feb 13, 2015 10-K 2015-03-02
Q3 2014 147M +5.25M +3.69% Oct 18, 2014 10-Q 2014-10-28
Q2 2014 147M +7.01M +5% Jul 18, 2014 10-Q 2014-07-31
Q1 2014 146M +6.92M +4.98% Apr 18, 2014 10-Q 2014-05-02
Q4 2013 144M Feb 14, 2014 10-K 2014-02-26
Q3 2013 142M +18.4M +14.8% Oct 18, 2013 10-Q 2013-10-28
Q2 2013 140M +16.6M +13.4% Jul 19, 2013 10-Q 2013-07-29
Q1 2013 139M +23.3M +20.1% Apr 19, 2013 10-Q 2013-04-29
Q3 2012 124M +9.61M +8.42% Oct 12, 2012 10-Q 2012-10-29
Q2 2012 124M +11.7M +10.5% Jul 13, 2012 10-Q 2012-08-02
Q1 2012 116M +4.79M +4.32% Apr 13, 2012 10-Q 2012-04-30
Q4 2011 115M Feb 13, 2012 10-K 2012-02-22
Q3 2011 114M +11.7M +11.4% Oct 15, 2011 10-Q 2011-10-31
Q2 2011 112M +9.77M +9.57% Jul 15, 2011 10-Q 2011-08-01
Q1 2011 111M Apr 15, 2011 10-Q 2011-04-29
Q3 2010 102M Oct 22, 2010 10-Q 2010-10-29
Q2 2010 102M Jul 23, 2010 10-Q 2010-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.